Differential effects of butyrate and dibutyryl cAMP on mRNA levels of muscarinic acetylcholine receptor subtypes expressed in neurohybrid cell lines

Neuroscience Letters

Volumn 212, Issue 1, 1996, Pages 49-52

  Fukamauchi, Fumihiko ^a   Mataga, Nobuko ^a   Wang, Yi Jun ^a   Chuang, De Maw ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Butyrate; Dibutyryl cAMP; Muscarinic acetylcholine receptor mRNA; NCB 20; NG108 15; Northern blot analysis

Indexed keywords

BUCLADESINE; BUTYRIC ACID; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M4 RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYBRID CELL; NEUROBLASTOMA CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0030570399     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12779-8     Document Type: Article

References (13)

1. [1] Belcheva, M.M., Barg, J., Mchale, R.J., Gao, X.-M., Chuang, D.-M. and Coscia, C.J., Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone, J. Pharmacol. Exp. Ther., 259 (1991) 302-309.
2. [2] Bonner, T.I., Buckley, N.J., Young, A.C. and Brann, M.R., Identification of a family of muscarinic acetylcholine receptor genes, Science, 237 (1987) 527-532.
3. [3] Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
4. [4] Coyle, J.T., Price, D.L. and DeLong, M.R., Alzheimer's disease: a disorder of cortical cholinergic innervation, Science, 219 (1983) 1184-1190.
5. [5] Fukamauchi, F., Hough, C. and Chuang, D.-M., Role of microtubule structure in the maintenance of m3-muscarinic acetylcholine receptor mRNA levels, Mol. Cell. Neurosci., 2 (1991) 123-129.
6. [6] Fukamauchi, F., Hough, C. and Chuang, D.-M., m2- and m3-Muscarinic acetylcholine receptor mRNAs have different responses to microtubule-affecting drugs, Mol. Cell. Neurosci., 2 (1991) 315-319.
7. [7] Hosey, M.M., Diversity of structure, signaling and regulation within the family of muscarinic cholinergic receptors, FASEB J., 6 (1992) 845-852.
8. [8] Mei, L., Roeske, W.R. and Yamamura, H.I., Molecular pharmacology of muscarinic receptor heterogeneity, Life Sci., 45 (1989) 1831-1851.
9. [9] Nuydens, R., Heers, C., Chadarevian, A., De Jong, M., Nuyens, R., Cornelissen, F. and Geerts, H., Sodium butyrate induces aberrant tau phosphorylation and programmed cell death in human neuroblastoma cells, Brain Res., 688 (1995) 86-94.
10. [10] Peralta, E.G., Ashkenazi, A., Winslow, J.W., Smith, D.H., Ramachandran, J. and Capon, D.J., Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors, EMBO J., 6 (1987) 3923-3929.
11. [11] Wood, I.C., Roopra, A., Harrington, C. and Buckley, N.J., Structure of the m4 cholinergic muscarinic receptor gene and its promoter, J. Biol. Chem., 270 (1995) 30933-30940.
12. [12] Zhu, X.-Z. and Chuang, D.-M., Comparison of the butyrate effects on neurotransmitter receptors in neurohybrids NG108-15 and NCB-20 cells, Life Sci., 41 (1987) 1133-1139.
13. [13] Zhu, X.-Z. and Chuang, D.-M., Differential regulation by butyrate and dibutyryl cyclic AMP of δ-opioid, α2-adrenergic, and muscarinic cholinergic receptors in NCB-20 cells, J. Neurochem., 50 (1988) 12-26.